Introduction: Cervical cancer remains a significant in brazilian's public health care affecting women across various age groups and in need of a effective control treatment. The Brazilian Guidelines for Cervical Cancer Screening, updated in 2016 (2nd edition, revised and expanded), have strengthened efforts to control this disease by emphasizing early detection and structured healthcare delivery. These guidelines highlight the role of Primary Healthcare (PHC) as the cornerstone of the healthcare system, focusing on prevention, health education, and exams. They also address Secondary and Tertiary Care, including procedures such as colposcopy and biopsy when abnormalities are detected, followed by further cytological evaluations or referrals to tertiary care facilities. Objectives: This study aims to evaluate the frequency of histopathological examinations across Brazil’s federative units and identify regions with the highest number of cases, analyzing variations in waiting times for these procedures. Methods: Data on waiting times for histopathological examinations were obtained from the DATASUS platform (TABNET) for the period spanning 2020 to 2024. The data were organized using Microsoft Excel, with records categorized by year and waiting time intervals: up to 30 days, up to 60 days, and over 60 days. Federative units with the highest examination frequencies were identified. Pivot tables facilitated data organization and analysis. All authors participated in the subsequent review and interpretation of the findings. Results: A total of 219,345 histopathological examinations were conducted in Brazil between 2020 and 2024. Of these, 139,917 (63.7%) were performed within 30 days, 50,180 (22.8%) within 31 to 60 days, and 29,248 (13.3%) took longer than 60 days. The state of Paraná accounted for the highest proportion of examinations, representing 14.5% of the total, followed closely by Minas Gerais with 14.3%. The year 2024 recorded the highest number of examinations, with 52,383 (23.8%) performed. Additionally, the most frequent waiting time interval was up to 30 days, which accounted for 22.7% of examinations in 2024. Conclusion: Cervical cancer exhibits a high prevalence in Brazil, impacting a significant number of women. The 219,345 histopathological examinations conducted during the study period reflect substantial national efforts to address this disease. The state of Paraná recorded the highest number of examinations, approximately 32,000, followed closely by Minas Gerais with around 31,000. These states consistently ranked among the highest in examination frequency, indicating heightened attention to cervical cancer incidence. Consequently, targeted governmental public health policies, particularly in federative units with elevated case rates, are essential to reduce the burden of this disease across the country.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
